Research we are currently funding:
This project will test and validate how new technologies could be utilised to monitor the concentration of chemotherapy in a patient’s blood in real-time.
This project will develop vital infrastructure that will make it easier for clinicians to choose the right treatment for individual patients.
This project aims to reduce the duration, cost and complications of fungal infections, with a significant reduction in cancer patients suffering.
The ultimate goal of the project is to inform appropriate care and improve outcomes for pregnant women with cancer and their babies.
The project will aim to develop online training interventions to improve communication, support and engagement with family carers, to help them feel empowered in their caregiving role.
Genetically modified immune cells can be used to cure cases of leukaemia that are otherwise incurable. This project will optimise the technology to create cures for other types of cancer.
This team is perfecting a new radiation dosimetry system that will detect and treat cancers as they move through the body.
This project will determine how drug resistance develops at the genetic level and explore ways of making treatment approaches more effective.
Professor Reddel’s research team are now testing drugs that block the source of this immortality – stopping tumour growth and triggering cancer cell death.
A/Prof Pickett aims to develop drugs that target the process cancers use to grow and thereby prevent cancer cell growth.
Professor Sanson-Fisher is implementing a new system of patient-centered care across NSW cancer treatment units.
Professor Wiggers is evaluating community programs and how well they reduce modifiable lifestyle risk factors for cancer.
A/Prof Claire Wakefield is testing interventions that provide support and improve long term outcomes to childhood cancer survivors and their families.
Dr Johnston and his team are researching whether an an anti-inflammatory drug could be used to prevent and treat the serious side effects of chemotherapy.
Impact we've achieved with our research:
Professor John Mattick and his team are using cutting-edge sequencing technologies to uncover various components of DNA and how they differ in cancer cells.
Lyndal Wellard-Cole and her team set out to determine what impact, if any, the legislation has had on the kilojoule content of Australian fast foods.
This study of 9,000 participants found that physical activity has the potential to lower someone’s cancer risk regardless of their body weight.
Research shows that 3,900 cases of cancers each year are related to being overweight. This research helps paint a picture of the extent of unhealthy marketing to children.
This research aims to improve the health and wellbeing of the estimated one million people living with and beyond cancer, as cancer survival rates continue to increase.